Pyruvate kinase (PK) is an essential enzyme in the metabolic pathways of all living organisms. It catalyzes the conversion of phosphoenolpyruvate (PEP) to pyruvate, a key step in glycolysis. In addition to its role in glycolysis, PK has been implicated in a variety of other metabolic processes, including the regulation of glucose uptake, the production of energy, and the control of cell growth and proliferation. Despite its importance, the enzymatic activity of PK is not well understood. This review will discuss the current understanding of PK and its potential applications in medicine.
PK is a member of the ATP-dependent family of enzymes, which includes other enzymes such as hexokinase and phosphofructokinase. It is composed of four subunits, two large (M1 and M2) and two small (R1 and R2). The M1 and M2 subunits are responsible for the catalytic activity of the enzyme, while the R1 and R2 subunits play a regulatory role. PK is an allosteric enzyme, meaning that its activity is regulated by the binding of other molecules, such as ATP and Mg2+. PK is involved in the conversion of PEP to pyruvate, which is the final step in glycolysis. This reaction is coupled to the hydrolysis of ATP, which is used to drive the conversion of PEP to pyruvate. The enzyme also plays a role in the regulation of glucose uptake, as it is involved in the phosphorylation of glucose to glucose-6-phosphate. Additionally, PK is involved in the production of energy, as it is necessary for the conversion of glucose to pyruvate, which is then used to generate ATP. Finally, PK is involved in the control of cell growth and proliferation, as it is necessary for the conversion of glucose to pyruvate, which is then used to generate the precursors for nucleic acid synthesis.
PK is regulated by a variety of factors, including the concentration of substrates, the presence of inhibitors, and the activity of other enzymes. The activity of PK is affected by the concentration of its substrates, PEP and ATP, as well as the concentration of its inhibitors, such as AMP and Mg2+. The activity of PK can also be affected by the activity of other enzymes, such as hexokinase, phosphofructokinase, and pyruvate dehydrogenase.
PK has several potential clinical applications. It has been suggested that PK could be used to regulate glucose uptake in diabetes, as it is involved in the phosphorylation of glucose. Additionally, PK could be used to regulate energy production, as it is necessary for the conversion of glucose to pyruvate. Finally, PK could be used to control cell growth and proliferation, as it is necessary for the conversion of glucose to pyruvate, which is then used to generate the precursors for nucleic acid synthesis.
Pyruvate kinase is an essential enzyme in the metabolic pathways of all living organisms. It plays a key role in the conversion of PEP to pyruvate, the regulation of glucose uptake, the production of energy, and the control of cell growth and proliferation. Despite its importance, the enzymatic activity of PK is not well understood. This review has discussed the current understanding of PK and its potential applications in medicine. Further research is necessary to unlock the full enzymatic potential of PK and to develop new therapeutic strategies for a variety of diseases.
1.
Le cancer et le COVID ont conduit le patient à une double transplantation de poumon.
2.
Effective for localizing small, non-palpable breast lesions is ultrasound-guided localization with magnetic seeds.
3.
Long-term study links chronic conditions in midlife to higher cancer risk and mortality
4.
Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients
5.
When does a melanoma metastasize? Implications for management
1.
Unlocking the Mysteries of Reticulocyte Counts: A Guide to Understanding Your Blood Results
2.
The Checkpoint Architect: Unraveling the Mechanisms of PD-L1 Regulation for the Next Generation of Small-Molecule Therapies
3.
Screening Efficacy, Molecular Precision, and Therapeutic Revolutions in Lung Cancer 2025
4.
Genetic Testing in Cancer Prevention: BRCA Mutations and Lynch Syndrome Unlocked
5.
Transforming Cancer Care: CAR T-Cell Therapy for Relapsed/Refractory NHL and ALL
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
4.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation